Patented high-efficiency gene editing tool enzyme for molecular detection and gene therapy applications including CAR-T cell development.
Manufactured by
China
Guangzhou Magigen Biotechnology manufactures molecular biology enzymes and reagents for IVD diagnostics and life sciences research, including CRISPR Cas proteins (Cas9, Cas12a, Cas13a), reverse transcriptases, Taq polymerase, LAMP isothermal amplification kits, and RNase inhibitors. The company also offers IVD CDMO production services for molecular diagnostic product development. No certification information was provided on the website.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
GeneCker Co., Ltd.
South Korea · 8 relevant products
Beijing SynsorBio Technology Co., Ltd
China · 3 relevant products
PreceDo Pharmaceuticals Co.Ltd.
China · 1 relevant product
Intelligenome
United States · 2 relevant products
Origin Biotechnology Co., Ltd.
Taiwan · 2 relevant products
Planet Innovation Pty Ltd.
United States · 1 relevant product
Beijing Jianping Jinxing Biomedical Co., Ltd
China · 1 relevant product
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 1 relevant product
GENETRON HEALTH (BEIJING) CO., LTD
China · 1 relevant product
6 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 27 closest product alternatives
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
GeneCker Co., Ltd. · South Korea
A diagnostic product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for genetic analysis. Part of GeneCker's one-stop cancer diagnosis platform that includes sample collection, DNA sequencing, and data output capabilities.
Beijing SynsorBio Technology Co., Ltd · China
Single-target CRISPR detection device for point-of-care testing applications. Integrates CRISPR-based molecular detection with microfluidics technology to enable rapid, accurate identification of specific nucleic acid targets in clinical specimens. Designed for decentralized diagnostic workflows requiring minimal infrastructure.
GeneCker Co., Ltd. · South Korea
Molecular diagnostic test using CRISPR/Cas9 technology to identify and amplify mutant DNA sequences in patient samples. Provides standardized detection and quantification of cancer-related genetic mutations.
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
PreceDo Pharmaceuticals Co.Ltd. · China
A collection of gene-edited cell lines created using CRISPR/Cas9 technology for functional genomics and target validation. These cells enable researchers to study specific genetic modifications relevant to disease mechanisms.
Beijing SynsorBio Technology Co., Ltd · China
A point-of-care testing system utilizing CRISPR technology for rapid nucleic acid detection. The system integrates microfluidics and synthetic biology for accurate identification of genetic sequences in clinical samples.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
GeneCker Co., Ltd. · South Korea
A cancer diagnosis platform product utilizing GeneCker's ultra-precision CRISPR/Cas9 technology for standardization of liquid biopsy diagnosis. Integrates sample collection, DNA sequencing via NGS or Sanger sequencing methods, and provides results in result booklet or PDF format.
Intelligenome · United States
IntelliGenome's proprietary CRISPR technology platform for decentralized diagnostics. Accurately detects pathogens and monitors treatment response across multiple applications including TB and oncology.
15 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products